CADL - Candel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CADL is currently covered by 3 analysts with an average price target of $13.74. This is a potential upside of $8.18 (147.12%) from yesterday's end of day stock price of $5.56.

Candel Therapeutics's activity chart (see below) currently has 3 price targets and 16 ratings on display. The stock rating distribution of CADL is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 4% with an average time for these price targets to be met of 18.8 days.

Highest price target for CADL is $25, Lowest price target is $7, average price target is $17.

Most recent stock forecast was given by ALEC STRANAHAN from BAML on 03-Sep-2025. First documented stock forecast 23-Aug-2021.

Best performing analysts who are covering CADL - Candel Therapeutics:

Evan Seigerman Judah Frommer Vernon Bernardino Alec Stranahan John Newman

Currently out of the existing stock ratings of CADL, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$1.44 (25.90%)

$15

1 months 2 days ago
(03-Sep-2025)

0/2 (0%)

$1.89 (36.99%)

Buy

$19

$13.44 (241.73%)

$19

5 months 24 days ago
(11-Apr-2025)

1/5 (20%)

$14.03 (282.29%)

94

Buy

$25

$19.44 (349.64%)

$20

7 months 9 days ago
(26-Feb-2025)

0/2 (0%)

$16.53 (195.16%)

Buy

$3

$1.3 (76.47%)

$18

2 years 4 months 21 days ago
(15-May-2023)

0/2 (0%)

$1.4 (87.50%)

Buy

2 years 6 months 4 days ago
(31-Mar-2023)

0/1 (0%)

$7.07 (89.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CADL (Candel Therapeutics) average time for price targets to be met?

On average it took 18.8 days on average for the stock forecasts to be realized with a an average price target met ratio 4

Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on CADL (Candel Therapeutics) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on CADL (Candel Therapeutics)?

Evan Seigerman works at BMO and has 26 price targets and 14 ratings on CADL

Which analyst is the currently most bullish on CADL (Candel Therapeutics)?

John Newman with highest potential upside - $19.44

Which analyst is the currently most reserved on CADL (Candel Therapeutics)?

Judah Frommer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?